Projects by EDCTP member countries: more than €250 million committed to NIDs
The EDCTP2 programme encompasses projects that are initiated and funded by its member countries independently. These so-called Participating States’ Initiated Activities (PSIAs) are considered a contribution to the programme if these are within the scope of the EDCTP programme and contribute to its objectives.
Between 2014-2019, African and European EDCTP member countries have supported 42 PSIAs on NTDs, with a combined indicative commitment of €250.8 million. These PSIAs cover diseases such as human African trypanosomiasis, dengue, hookworm, lymphatic filariasis and leprosy, amongst others. They also include support to NID-related activities conducted by product development partnerships such as the Drugs for Neglected Diseases initiative, the European Vaccine Initiative, the Dengue Vaccine Initiative, the Sabin Vaccine Institute and the Foundation for Innovative New Diagnostics.
Spain, for example, through its institutional support to the National Centre for Epidemic Control in Equatorial Guinea, has funded the development and implementation of the national plan to combat HAT, onchocerciasis and other filariasis control programmes in Equatorial Guinea.
Finland is supporting sampling and epidemiological work in Tanzania, Ethiopia and Kenya to develop innovative, non-invasive sampling methods to detect dengue virus infections in order to establish the disease burden in Africa and consider threats of other arboviruses. This research is helping to increase awareness and understanding of the emerging epidemiology and burden of dengue in Africa and to provide capacity-building for dengue surveillance.
Zambia supports work to increase clinical awareness of leprosy and improve detection rates of new leprosy cases in Zambia, to evaluate new leprosy diagnostic tests, and to apply next-generation sequencing for rapid diagnosis of leprosy and defining M.leprae strains and susceptibility to anti-leprosy drugs.